Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

INTRODUCTION: We report the SVR12 final analysis of a phase 3 study of telaprevir in combination with peginterferon (P)/ribavirin (R) in HCV-genotype 1, treatment-naïve and -experienced patients with HCV/HIV co-infection (INSIGHT). MATERIALS AND METHODS: Patients receiving stable, suppressive HIV an...

Descripción completa

Detalles Bibliográficos
Autores principales: Montes, Marisa, Nelson, Mark, Marie Girard, Pierre, Sasadeusz, Joe, Horban, Andrzej, Grinsztejn, Beatriz, Zakharova, Natalia, Rivero, Antonio, Lathouwers, Erkki, Janssen, Katrien, Ouwerkerk-Mahadevan, Sivi, Witek, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P094
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224845/
https://www.ncbi.nlm.nih.gov/pubmed/25394130
http://dx.doi.org/10.7448/IAS.17.4.19626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224845/
https://www.ncbi.nlm.nih.gov/pubmed/25394130
http://dx.doi.org/10.7448/IAS.17.4.19626

Ejemplares similares